Meredith Cook
General Counsel bei ANI PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Meredith Cook
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANI PHARMACEUTICALS, INC. | General Counsel | 18.07.2022 | - |
Unternehmenssekretär | 18.07.2022 | - |
Karriereverlauf von Meredith Cook
Ehemalige bekannte Positionen von Meredith Cook
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Meredith Cook
Princeton University | Undergraduate Degree |
Tulane University Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
General Counsel | 1 |
Corporate Secretary | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Meredith Cook
- Erfahrung